| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d94573ab2c57e8b193f3a22accddf9fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 |
| filingDate |
2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_647c691a3856970745ae057e5be9ea94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_695292b601dedf6a28dd47df97ed9502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c3f5675094c6b3287736c9eebc7429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc80534a7a83def409aaebfd9c278881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c8034887ac07ae0877179d56edce407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34e75da75fd07b8b794448b8cb81c246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f9f55fbea817d99806ef6fd5f2417b2 |
| publicationDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111346096-A |
| titleOfInvention |
A pharmaceutical composition for preventing or treating glioma |
| abstract |
The present invention provides a pharmaceutical composition for treating glioma, which comprises a therapeutically effective amount of Tamatinib or its prodrug or pharmaceutically acceptable salt, and a therapeutically effective amount of temozolomide or its prodrug or pharmaceutically acceptable salt. The present invention also provides a kit for treating glioma, the kit comprising a first pharmaceutical composition and a second pharmaceutical composition, the first pharmaceutical composition comprising a therapeutically effective amount of Tamatinib or a prodrug thereof or a pharmaceutically acceptable salt, the second pharmaceutical composition comprises a therapeutically effective amount of temozolomide or a prodrug or a pharmaceutically acceptable salt thereof. The present invention further provides the use of Tamatinib or a prodrug or pharmaceutically acceptable salt thereof as a sensitizer for chemotherapeutic drugs for the treatment of glioma. |
| priorityDate |
2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |